Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKromek Regulatory News (KMK)

Share Price Information for Kromek (KMK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6.20
Bid: 6.00
Ask: 6.40
Change: -0.10 (-1.59%)
Spread: 0.40 (6.667%)
Open: 6.30
High: 6.30
Low: 6.20
Prev. Close: 6.30
KMK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Nuclear security contract with new OEM customer

26 Feb 2019 07:00

RNS Number : 0757R
Kromek Group PLC
26 February 2019
 

26 February 2019 

 

Kromek Group plc

("Kromek" or the "Company")

 

Kromek secures multi-year nuclear security contract with new OEM customer

 

Kromek (AIM: KMK), a worldwide supplier of detection technology focusing on the medical, security screening and nuclear markets, is pleased to announce that it has been awarded a contract by a new OEM customer to supply CZT detectors for use in the nuclear security market.

 

The contract, which commences immediately, is worth at least $1.4 million and will be delivered over a three-year period, with minimum annual volumes for each year.

 

Arnab Basu, CEO of Kromek, commented: "It is very pleasing to sign another multi-year contract with a new OEM customer in the nuclear security market. This further validates the strength of our high-resolution detectors that enable accurate identification of threats. The contract increases our visibility of future revenue and, with our recent fundraising, we are better able to capitalise on similar opportunities in this fast-growing market."

 

 

For further information, please contact:

 

Kromek Group plc

Arnab Basu, CEO

Derek Bulmer, CFO

 

+44 (0)1740 626 060

Cenkos Securities plc

Max Hartley (NOMAD)

Julian Morse (Sales)

 

+44 (0)20 7397 8900

Luther Pendragon Ltd

Harry Chathli

Claire Norbury

Alexis Gore

Joe Quinlan

+44 (0)20 7618 9100

 

About Kromek Group plc

 

Kromek Group plc is a technology group (global HQ in County Durham) and a leading developer of high performance radiation detection products based on cadmium zinc telluride ("CZT") and other advanced technologies. Using its core technology platforms, Kromek designs, develops and produces x-ray and gamma ray imaging and radiation detection products for the medical, security screening and nuclear markets.

 

The Group's products provide high resolution information on material composition and structure and are used in multiple applications, ranging from the identification of cancerous tissues to hazardous materials, such as explosives, and the analysis of radioactive materials.

 

The Group's business model provides a vertically integrated technology offering to customers, from radiation detector materials to finished products or detectors, including software, electronics and application specific integrated circuits ("ASICs").

 

The Group has operations in the UK and US (California and Pennsylvania), and is selling internationally through a combination of distributors and direct OEM sales.

 

Currently, the Group has over one hundred full-time employees across its global operations. Further information on Kromek Group is available at www.kromek.com and https://twitter.com/kromekgroup.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
CNTSEWEEIFUSEIE
Date   Source Headline
27th Nov 20137:00 amRNSBottle Scanner Orders and New Accreditation
5th Nov 20137:00 amRNSOrders and payments received from global OEMs
31st Oct 20131:28 pmRNSTotal Voting Rights
24th Oct 201311:44 amRNSHolding(s) in Company
21st Oct 20136:08 pmRNSHolding(s) in Company
16th Oct 20137:00 amRNSAdmission and First Day of Dealings on AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.